Literature DB >> 19167723

Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years.

Nathalie Guffon1, Yves Bertrand, Isabelle Forest, Alain Fouilhoux, Roseline Froissart.   

Abstract

OBJECTIVE: To evaluate the effect of bone marrow transplantation in children with Hunter syndrome. STUDY
DESIGN: Eight boys received a bone marrow graft between the ages of 3 and 16 years from 1990 to 2000. In 6 cases, the donor was a sibling with identical HLA status, in 1 case an unrelated donor with HLA-compatible, and in 1 case a mismatched unrelated donor. A complete multidisciplinary evaluation was performed yearly.
RESULTS: Successful engraftment was achieved in all patients, with the proportion of donor cells reaching > or =95% 1 month after transplantation in all patients. Patients have been followed from between 7 and 17 years and all are still alive, except for 1 boy who died at the age of 10 from unrelated causes. Cardiovascular abnormalities stabilized in all patients, hepatosplenomegaly resolved, and joint stiffness improved, Perceptual hearing defects remained stable, and transmission hearing defects improved. Only 1 child required subsequent surgery to correct kyphosis. Neuropsychological outcome was variable and appeared to be related to the severity of the syndrome.
CONCLUSIONS: Bone marrow transplantation is effective on the no neuropsychological symptoms of Hunter disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167723     DOI: 10.1016/j.jpeds.2008.11.041

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  52 in total

1.  Newborn Screening for Lysosomal Storage Disorders: Views of Genetic Healthcare Providers.

Authors:  Emily C Lisi; Shawn E McCandless
Journal:  J Genet Couns       Date:  2015-08-29       Impact factor: 2.537

Review 2.  Lysosomal storage disease overview.

Authors:  Angela Sun
Journal:  Ann Transl Med       Date:  2018-12

Review 3.  Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future.

Authors:  Madeleine Taylor; Shaukat Khan; Molly Stapleton; Jianmin Wang; Jing Chen; Robert Wynn; Hiromasa Yabe; Yasutsugu Chinen; Jaap Jan Boelens; Robert W Mason; Francyne Kubaski; Dafne D G Horovitz; Anneliese L Barth; Marta Serafini; Maria Ester Bernardo; Hironori Kobayashi; Kenji E Orii; Yasuyuki Suzuki; Tadao Orii; Shunji Tomatsu
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-14       Impact factor: 5.742

Review 4.  Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.

Authors:  Adeline A Lau; Kim M Hemsley
Journal:  J Mol Med (Berl)       Date:  2017-06-29       Impact factor: 4.599

Review 5.  Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses.

Authors:  Dao Pan
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

6.  Effectiveness of Early Hematopoietic Stem Cell Transplantation in Preventing Neurocognitive Decline in Mucopolysaccharidosis Type II: A Case Series.

Authors:  A Selvanathan; C Ellaway; C Wilson; P Owens; P J Shaw; K Bhattacharya
Journal:  JIMD Rep       Date:  2018-04-19

Review 7.  Therapies for the bone in mucopolysaccharidoses.

Authors:  Shunji Tomatsu; Carlos J Alméciga-Díaz; Adriana M Montaño; Hiromasa Yabe; Akemi Tanaka; Vu Chi Dung; Roberto Giugliani; Francyne Kubaski; Robert W Mason; Eriko Yasuda; Kazuki Sawamoto; William Mackenzie; Yasuyuki Suzuki; Kenji E Orii; Luis A Barrera; William S Sly; Tadao Orii
Journal:  Mol Genet Metab       Date:  2014-12-09       Impact factor: 4.797

Review 8.  Recent trends in mucopolysaccharidosis research.

Authors:  Hiroshi Kobayashi
Journal:  J Hum Genet       Date:  2018-11-19       Impact factor: 3.172

9.  Hematopoietic stem cell transplantation for Morquio A syndrome.

Authors:  Hiromasa Yabe; Akemi Tanaka; Yasutsugu Chinen; Shunichi Kato; Kazuki Sawamoto; Eriko Yasuda; Haruo Shintaku; Yasuyuki Suzuki; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2015-10-01       Impact factor: 4.797

10.  Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis.

Authors:  Rolando Cimaz; Giovanni Valentino Coppa; Isabelle Koné-Paut; Bianca Link; Gregory M Pastores; Maria Rua Elorduy; Charles Spencer; Carter Thorne; Nico Wulffraat; Bernhard Manger
Journal:  Pediatr Rheumatol Online J       Date:  2009-10-23       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.